Compounds > n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide
Page last updated: 2024-09-02

n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide and Facial Pain

n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide has been researched along with Facial Pain in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baguley, BC; Evans, BD; Harvey, VJ; McCrystal, MR; Porter, DJ; Thompson, PI1

Trials

1 trial(s) available for n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide and Facial Pain

ArticleYear
Phase I study of the cytotoxic agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
    Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:1

    Topics: Acridines; Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Facial Pain; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms

1999